Bogart Wealth, LLC Edwards Lifesciences Corp Transaction History

Bogart Wealth, LLC

$2.11 Billion
Q1 2025

A detailed history of Bogart Wealth, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Bogart Wealth, LLC holds 1,040 shares of EW stock, worth $78,884. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,040

Previous 92,768 98.88%

Holding current value

$78,884

Previous $6.87 Million 98.91%

% of portfolio

0.0%

Previous 0.33%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 01, 2025	SELL	$67.95 - $76.19 $6.23 Million - $6.99 Million	-91,728 Reduced 98.88%	1,040 $75,000
Q4 2024 Jan 29, 2025	BUY	$64.54 - $75.92 $1.66 Million - $1.95 Million	25,657 Added 38.23%	92,768 $6.87 Million
Q3 2024 Oct 22, 2024	BUY	$59.7 - $93.78 $322,857 - $507,162	5,408 Added 8.76%	67,111 $4.43 Million
Q2 2024 Jul 31, 2024	BUY	$84.3 - $94.31 $5.2 Million - $5.82 Million	61,703 New	61,703 $5.7 Million
Q2 2023 Jul 28, 2023	SELL	$81.41 - $94.33 $3,907 - $4,527	-48 Reduced 67.61%	23 $2,000
Q1 2023 Apr 21, 2023	SELL	$74.26 - $84.51 $17,748 - $20,197	-239 Reduced 77.1%	71 $5,000
Q4 2022 Feb 06, 2023	BUY	$68.3 - $87.44 $683 - $874	10 Added 3.33%	310 $23,000
Q3 2022 Nov 03, 2022	BUY	$82.37 - $107.29 $24,711 - $32,187	300 New	300 $25,000
Q2 2022 Jul 22, 2022	SELL	$86.5 - $128.27 $184,764 - $273,984	-2,136 Closed	0 $0
Q4 2020 Jan 14, 2021	BUY	$71.69 - $91.23 $21,507 - $27,369	300 Added 16.34%	2,136 $194,000
Q2 2020 Jul 08, 2020	BUY	$57.54 - $76.95 $70,428 - $94,186	1,224 Added 200.0%	1,836 $127,000
Q2 2018 Jul 13, 2018	SELL	$42.45 - $51.3 $14,433 - $17,442	-340 Reduced 35.71%	612 $89,000
Q1 2018 Apr 13, 2018	BUY	$37.19 - $47.45 $35,404 - $45,172	952 New	952 $134,000

Others Institutions Holding EW

# of Institutions

1,376

Shares Held

486M

Call Options Held

2.77M

Put Options Held

2.05M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bogart Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bogart Wealth, LLC with notifications on news.

Account

Bogart Wealth, LLC Edwards Lifesciences Corp Transaction History